Two- and three-color cytofluorimetric techniques were used to study the expression patterns of the activation antigen HLA-DR on peripheral blood immunoregulatory T-cells from 25 patients with newly diagnosed insulin-dependent diabetes mellitus (IDDM) and 14 age- and sex-matched control subjects. The mean percentage of total activated (CD3+HLA-DR+) T-cells was significantly elevated in the IDDM group compared with the control group (P < 0.001). In control subjects, basal activation of CD4+ and CD8+ lymphocytes accounted for the low percentage levels of activated T-cells. In contrast, the majority of IDDM patients showed an unbalanced activation of CD4+ and CD8+ lymphocytes with predominant activation of the CD8+ lymphocyte subset. The composition of the activated T-cell fraction was dependent on the composition of the total (activated + nonactivated) T-cell population, as indicated by the positive correlation between the CD4+/CD8+ T-cell ratios in these two cell populations (r = 0.714; P < 0.001). Excessive activation of CD8+ T-cells was attributable to similar increases in the proportions of CD8+CD45RA+HLA-DR+ (naive) and CD8+CD45RA−HLA-DR+ (memory) cells. Analysis of the CD11b-defined subsets revealed predominant activation of CD8+ CD11b− (cytotoxic) T-cells; CD8+CD16+ HLA-DR+ natural killer cells wereunchanged. The distribution of HLA-DR+ cells among subsets of CD4+ T-cells differed from the pattern in the CD8+ population in that selective activation of CD4+ CD45RA− (memory, helper-inducer) cells accounted for the small increase in activated CD4+ cells. The present findings suggest an important role for CD8+ T-lymphocytes in IDDM and raise the possibility that these lymphocytes might be the relevant target for early immunotherapy in patients with recent disease onset.
Skip Nav Destination
Article navigation
Original Articles|
December 01 1995
Aberrant Activation of CD8+ T-cell and CD8+ T-Cell Subsets in Patients With Newly Diagnosed IDDM
Bernd Hehmke;
Bernd Hehmke
Department of Experimental and Clinical Endocrinology, Institute of Diabetes “Gerhardt Katsch,” University of Greifswald
Karlsburg
Search for other works by this author on:
Dietrich Michaelis;
Dietrich Michaelis
Clinic of Diabetes and Metabolic Diseases
Karlsburg
Search for other works by this author on:
Elke Gens;
Elke Gens
Clinic of Diabetes and Metabolic Diseases
Karlsburg
Search for other works by this author on:
Klaus-Dieter Kohnert
Klaus-Dieter Kohnert
Department of Experimental and Clinical Endocrinology, Institute of Diabetes “Gerhardt Katsch,” University of Greifswald
Karlsburg
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Bernd Hehmke, Department of Experimental and Clinical Endocrinology, Institute of Diabetes “Gerhardt Katsch,” D-17495 Karlsburg, Germany.
1
FBS, fetal bovine serum; FITC, fluorescein isothiocyanate; ICA, islet cell antibody; IDDM, insulin-dependent diabetes mellitus; IFN, interferon; IL, interleukin; mAb, monoclonal antibody; NK, natural killer; PBMC, peripheral mononuclear cells; PBS, phosphate-buffered saline; PE, R-phycoerythrin; SA, streptavidin; TR, Texas Red.
Diabetes 1995;44(12):1414–1419
Article history
Received:
February 14 1995
Revision Received:
August 10 1995
Accepted:
August 10 1995
PubMed:
7589848
Citation
Bernd Hehmke, Dietrich Michaelis, Elke Gens, Frank Laube, Klaus-Dieter Kohnert; Aberrant Activation of CD8+ T-cell and CD8+ T-Cell Subsets in Patients With Newly Diagnosed IDDM. Diabetes 1 December 1995; 44 (12): 1414–1419. https://doi.org/10.2337/diab.44.12.1414
Download citation file:
68
Views